Protection of live Mycobacterium habana vaccine against Mycobacterium tuberculosis H37Rv challenge in mice

Indian Journal of Medical Research

Volumn 117, Issue APR., 2003, Pages 139-145

  Raj, P Prem ^a   Srivastava, S ^a   Jain, S K ^b   Srivastava, B S ^a   Srivastava, R ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b HAMDARD UNIVERSITY   (India)

Author keywords

M. tuberculosis challenge; Mycobacterium habana vaccine; Protection; Tuberculosis

Indexed keywords

MYCOBACTERIUM HABANA VACCINE; MYCOBACTERIUM VACCINE; UNCLASSIFIED DRUG; VACCINE;

ACID FAST BACTERIUM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; BRONCHOPNEUMONIA; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HISTOPATHOLOGY; IMMUNE DEFICIENCY; IMMUNIZATION; LIVER; LUNG TUBERCULOSIS; MICROBIOLOGICAL PARAMETERS; MOUSE; MOUSE STRAIN; MYCOBACTERIUM; MYCOBACTERIUM HABANA; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROVOCATION TEST; SPLEEN; SURVIVAL; SURVIVAL TIME; TUBERCULOSIS;

ANIMALS; BACTERIAL VACCINES; COLONY COUNT, MICROBIAL; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; LUNG; MICE; MICE, INBRED AKR; MICE, INBRED STRAINS; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; VACCINATION;

EID: 0142042922     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Raviglione MC, Snider DE Jr, Kochi A. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA 1995; 273 : 220-6.
2. Tuberculosis Research Centre, ICMR. Fifteen year follow up of trial of BCG vaccines in South India for tuberculosis prevention. Indian J Med Res 1999; 110 : 56-9.
3. Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV, et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 1994; 271 : 698-702.
4. Kaufmann SH, Hess J. Immune response against Mycobacterium tuberculosis: Implications for vaccine development. J Biotechnol 2000; 83 : 13-7.
5. Young DB, Kaufmann SH, Hermans PW, Thole JE. Mycobacterial protein antigens: A compilation. Mol Microbiol 1992; 6 : 133-45.
6. Srivastava R, Srivastava BS. Tuberculosis vaccines. I Drugs 2000; 3 : 408-15.
7. Hondalus MK, Bardarov S, Russell R, Chan J, Jacobs WR Jr, Bloom BR. Attenuation of/and protection induced by a leucine auxotroph of Mycobacterium tuberculosis. Infect Immun 2000; 68 : 2888-98.
8. Horwitz MA, Harth G, Dillon BJ, Maslesa-Galic S. Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model. Proc Natl Acad Sci USA 2000; 97 : 13853-8.
9. Gupta HP, Singh NB, Mathur IS, Gupta SK. Mycobacterium habana, a new immunogenic strain in experimental tuberculosis of mice. Indian J Exp Biol 1979; 17 : 1190-3.
10. Singh IG, Mukherjee R, Talwar GP. Resistance to intravenous inoculation of Mycobacterium tuberculosis H37Rv in mice of different inbred strains following immunization with a leprosy vaccine based on Mycobacterium w. Vaccine 1991; 9 : 10-4.
11. Johnson JL, Kamya RM, Okwera A, Loughlin AM, Nyole S, Hom DL, et al. Randomized controlled trial of Mycobacterium vaccae immunotherapy in non-human immunodeficiency virus-infected Ugandan adults with newly diagnosed pulmonary tuberculosis. The Uganda-Case Western Reserve University Research Collaboration. J Infect Dis 2000; 181 : 1304-12.
12. Jensen KA. Towards a standardisation of laboratory methods. Second Report of the Subcommittee of Laboratory Methods of the International Union Against Tuberculosis. Bull Int Union Tuberc 1955; 25 : 89-104.
13. Mitchison DA, Allen BW, Carrol L, Dickinson JM, Aber VR. A selective oleic acid albumin agar medium for tubercle bacilli. J Med Microbiol 1972; 5 : 165-75.
14. Gupta SK, Sen N. The spleen, liver and lung weights in experimental tuberculosis of guinea-pigs. Indian J Med Res 1959; 47 : 382-7.
15. Job CK, Chacko CJ. A modification of Fite's stain for demonstration of M. leprae in tissue sections. Indian J Lepr 1986; 58 : 17-8.
16. Stevens A. The haematoxylins. In: Bancroft JD, Stevens A, editors. Theory and Practice of Histological Techniques. Edinburgh: Churchill Livingstone; 1990 p. 7-18.
17. Roberts AD, Sonnenberg MG, Ordway DJ, Furney SK, Brennan PJ, Belisle JT, et al. Characteristics of protective immunity engendered by vaccination of mice with purified culture filtrate protein antigens of Mycobacterium tuberculosis. Immunology 1995; 85 : 502-8.
18. Chaturvedi V, Srivastava A, Gupta HP, Srivastava BS. Protective antigens of Mycobacterium habana are distributed between peripheral and integral compartments of plasma membrane: A study in experimental tuberculosis of mouse. Vaccine 1999; 17 : 2882-7.
19. Singh NB, Lowe AC, Rees RJ, Colston MJ. Vaccination of mice against Mycobacterium leprae infection. Infect Immun 1989; 57 : 653-5.
20. Singh NB, Srivastava A, Gupta HP, Kumar A, Chaturvedi VK. Relative cross reactivity of habanin, lepromin and tuberculin in guinea pigs sensitized with homologous and heterologous mycobacteria. Indian J Lepr 1988; 60 : 407-12.